FLA-IDA salvage chemotherapy combined with a seven-day course of venetoclax (FLAVIDA) in patients with relapsed/refractory acute leukaemia

Br J Haematol. 2020 Feb;188(3):e11-e15. doi: 10.1111/bjh.16268. Epub 2019 Nov 4.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Adolescent
  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
  • Bridged Bicyclo Compounds, Heterocyclic / administration & dosage
  • Cytarabine / administration & dosage
  • Female
  • Granulocyte Colony-Stimulating Factor / administration & dosage
  • Humans
  • Leukemia / drug therapy*
  • Male
  • Middle Aged
  • Recurrence
  • Salvage Therapy*
  • Sulfonamides / administration & dosage
  • Vidarabine / administration & dosage
  • Vidarabine / analogs & derivatives

Substances

  • Bridged Bicyclo Compounds, Heterocyclic
  • Sulfonamides
  • Cytarabine
  • Granulocyte Colony-Stimulating Factor
  • Vidarabine
  • venetoclax
  • fludarabine